All posts by mflakecooleycom

SEC Amendments to Financial Disclosure Requirements Provide a Welcome Reprieve for Carve-Out Transactions

As previously reported in this Cooley PubCo post, on May 21, the SEC adopted final amendments to the financial disclosure requirements for the acquisition and disposition of businesses. One change relating to the use of abbreviated financial statements stands out as a welcome reform for public or pre-public biopharma and […]